---
title: An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department
nct_id: NCT01899365
overall_status: COMPLETED
sponsor: Centre Hospitalier Princesse Grace
study_type: OBSERVATIONAL
primary_condition: Pneumococcal Infections
countries: France, Monaco
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01899365.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01899365"
ct_last_update_post_date: 2020-01-23
last_seen_at: "2026-05-12T06:31:44.385Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department

**Official Title:** An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department; A Multicenter Prospective Randomized Open Trial The IMPROVED Project

**NCT ID:** [NCT01899365](https://clinicaltrials.gov/study/NCT01899365)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 1475
- **Lead Sponsor:** Centre Hospitalier Princesse Grace
- **Collaborators:** Centre Scientifique de Monaco, Pfizer
- **Conditions:** Pneumococcal Infections
- **Start Date:** 2015-11
- **Completion Date:** 2017-10
- **CT.gov Last Update:** 2020-01-23

## Brief Summary

Background :

Community-acquired pneumonia (CAP) is a threat in industrialized countries. It represents the 6th cause of death. CAP also frequently associates with other disorders responsible for admission and death. Among bacteria responsible for CAP, Streptococcus pneumonia is a major pathogen that is commonly involved and frequently leads to severe infection and admission. Categories at risk for this pathogen have been determined, and can be proposed anti-pneumococcal vaccination (APV) that efficiently and safely protects from this microorganism.

In the context of US health services, monocenter pilot experiences have reported improvement of pneumococcal prophylaxis implementing vaccination procedure at ED. A study that set in New Mexico (2003) reported a significant increase in APV (from 18% to 84%) when patients at risk were proposed vaccination at ED. To obtain these results, medical students were specifically trained and dedicated to screen and vaccinate against St. pneumoniae. Another single center trial (Tennessee, 2007) for APV at ED obtained an improvement (from 38.8 to 45.4%) when physicians were alerted for pneumococcal risk by the software they usually utilized at bedside. However these experiences remain sparse as additional dedicated resources are required or patients and attending ED physicians can be reluctant to proceed to vaccination at ED.

Mobile phone and derived communication modalities are current vectors to deliver information in several fields including education and medicine. Initially used in developing countries, short-message services (SMS) have improved behaviour of patients in various medical areas. In France, the investigators have observed that most patients above 50 years of age admitted after ED visit are equipped with mobile phone and can receive alerts by SMS.

These observations prompt us to propose a multifaceted procedure to improve APV after ED visit in at-risk patients, combining structured oral interview, written information and SMS as reminders.

Purpose : The investigators hypothesized that

* a multifaceted intervention to promote anti-pneumococcal vaccination combining a structured oral interview, a written information to patient and his/her general practitioner, and a series of 3 SMS,
* improves anti-pneumococcal vaccination at 6 months,
* in at-risk patients (65+ years) visiting the emergency department. In order to answer this question, the investigators designed an interventional prospective multicenter randomized study (cluster).

## Eligibility

- **Minimum age:** 65 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* patients 65-year old and above,
* benefit from French or Monaco social security a social security.

Exclusion Criteria:

* refuse to participate,
* no possibility to receive SMS,
* impaired cognitive functions and mental status precluding understanding of the study,
* anticipated barriers precluding adequate follow-up (ex. homeless),
* previous APV,
* contraindication to APV,
* do not understand/read French.
```

## Arms

- **Multifaceted** — * brief structured interview with the physician about pneumococcal risk and vaccination,
* information sheet delivered to patients with explanation about risk and benefit of APV,
* letter given to patient for his/her general practitioner stating that the patient is at-risk for pneumococcal infection and could benefit of APV,
* 3 SMS every 2 weeks to remind patients talking of pneumococcal risk with general practitioner.
- **Control** — * information sheet delivered to patients with explanation about the aim of the study,
* brief interview with the physician about study.

## Primary Outcomes

- **Impact of a multifaceted procedure at ED visit on anti-pneumococcal vaccination. (APV) at 6-month. Evaluation criteria : Δ percentage (%) of APV vaccination at 6-month** _(time frame: 6 month)_

## Secondary Outcomes

- **On Flu vaccination at 6-month Δ percentage (%)** _(time frame: 6 month)_
- **On episodes of respiratory tract infections requiring antibiotics or admission at 6-month Δ (absolute number of events)** _(time frame: 6 month)_
- **On death at 6- and 12-month (absolute number of events)** _(time frame: 6 month)_
- **On death related to infection at 6- and 12-month (absolute number of events)** _(time frame: 6 month)_
- **Psychosocial evaluation of patients and acceptance / refusal of vaccination** _(time frame: 6 month)_

## Locations (18)

- Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
- Centre Hospitalier Paul Ardier, Issoire, France
- AP-HM - Hôpital Nord, Marseille, France
- AP-HM - La Timone, Marseille, France
- HIA Laveran, Marseille, France
- Centre Hospitalier La Palmosa, Menton, France
- Centre Hospitalier Universitaire de Nice, Nice, France
- Centre Hospitalier Louis Giorgi, Orange, France
- Hôpital Lariboisière, Paris, France
- Hôpital Pitié-Salpêtrière, Paris, France
- Hôpital Bichat-Claude Bernard, Paris, France
- Hôpital Tenon, Paris, France
- Hôpital Cochin, Paris, France
- Centre hospitalier de Saint-Denis, Saint-Denis, France
- Centre Hospitalier de Vaison-la-Romaine, Vaison-la-Romaine, France
- Centre Hospitalier Jules Niel, Valréas, France
- Centre Hospitalier Jacques Lacarin, Vichy, France
- Centre Hospitalier Princesse Grace, Monaco, Monaco

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.centre hospitalier universitaire de clermont-ferrand|clermont-ferrand||france` — added _(2026-05-12)_
- `locations.centre hospitalier paul ardier|issoire||france` — added _(2026-05-12)_
- `locations.ap-hm - hôpital nord|marseille||france` — added _(2026-05-12)_
- `locations.ap-hm - la timone|marseille||france` — added _(2026-05-12)_
- `locations.hia laveran|marseille||france` — added _(2026-05-12)_
- `locations.centre hospitalier la palmosa|menton||france` — added _(2026-05-12)_
- `locations.centre hospitalier universitaire de nice|nice||france` — added _(2026-05-12)_
- `locations.centre hospitalier louis giorgi|orange||france` — added _(2026-05-12)_
- `locations.hôpital lariboisière|paris||france` — added _(2026-05-12)_
- `locations.hôpital pitié-salpêtrière|paris||france` — added _(2026-05-12)_
- `locations.hôpital bichat-claude bernard|paris||france` — added _(2026-05-12)_
- `locations.hôpital tenon|paris||france` — added _(2026-05-12)_
- `locations.hôpital cochin|paris||france` — added _(2026-05-12)_
- `locations.centre hospitalier de saint-denis|saint-denis||france` — added _(2026-05-12)_
- `locations.centre hospitalier de vaison-la-romaine|vaison-la-romaine||france` — added _(2026-05-12)_
- `locations.centre hospitalier jules niel|valréas||france` — added _(2026-05-12)_
- `locations.centre hospitalier jacques lacarin|vichy||france` — added _(2026-05-12)_
- `locations.centre hospitalier princesse grace|monaco||monaco` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01899365.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01899365*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*